Recrudescence of Focal Stroke Symptoms during Pain Management with Hydromorphone
نویسندگان
چکیده
Patients who have recovered from a prior stroke may experience a reemergence of their original stroke syndrome secondary to metabolic derangements, sedation, infection, and/or fatigue. Critically, the molecular/cellular mechanisms mediating symptom recurrence after exposure to analgesic agents remain unknown. Accordingly, herein, we report a unique case of a patient with hydromorphone-induced recrudescence 30 years after her initial stroke event(s) and in so doing propose a putative mechanism related to post-infarction functional neuroplasticity.
منابع مشابه
Managing cancer pain and symptoms of outpatients by rotation to sustained-release hydromorphone: a prospective clinical trial.
PURPOSE In this prospective clinical trial we examined the technique of opioid rotation to oral sustained-release hydromorphone for controlling pain and symptoms in outpatients with cancer pain. METHODS Before and after rotation, 50 patients were assessed by Numerical Analog Scales [Numerical Rating Scales (NRS)], or as categorical parameters, and analyzed by descriptive and confirmatory stat...
متن کاملIntrathecal hydromorphone for postoperative analgesia after cesarean delivery: a retrospective study.
Despite compelling evidence for the safety and efficacy of intrathecal hydromorphone, the use of this opioid intrathecally for the pain management of patients undergoing cesarean delivery has not been widely accepted. The purpose of this retrospective study was to compare the reported efficacy and safety of pain management in women who received intrathecal hydromorphone (100 microg) vs in women...
متن کاملPain management in chronic kidney disease: the pharmacokinetics and pharmacodynamics of hydromorphone and hydromorphone-3-glucuronide in hemodialysis patients.
OBJECTIVE To describe the pharmacokinetics of hydromorphone (HM) and its primary metabolite hydromorphone-3-glucuronide (H3G) both on and off dialysis in relation to the pharmacodynamic measurements of pain. DESIGN Prospective, open-label, observational study. SETTING Canadian, university-based renal program. PARTICIPANTS Twelve anuric hemodialysis patients with chronic pain, established ...
متن کاملOnce-daily OROS® hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study
BACKGROUND The use of opioid analgesics for patients with chronic nonmalignant pain is becoming more widely accepted, and long-acting formulations are an important treatment option. AIM To assess conversion to extended-release OROS hydromorphone from previous stable opioid agonist therapy in patients with chronic nonmalignant pain of moderate-to-severe intensity. METHODS In this open-label ...
متن کاملFriday , October 9 Physician Education and Outcomes 1 . Pain medications : Improving patient care by changing physician performance
Friday, October 9 Physician Education and Outcomes 1. Pain medications: Improving patient care by changing physician performance Presenter: Meghan Gannon, MSPH Authors: Amir Qaseem, MD, PhD, MHA, American College of Physicians; Meghan Gannon, MSPH, American College of Physicians Background: Appropriate pain assessment and management is one of the most important issues primary care physicians fa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 7 شماره
صفحات -
تاریخ انتشار 2016